Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,561 INR | +3.13% | +6.53% | +23.72% |
14/05 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
10/05 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
Sales 2024 | 15.59B 187M | Sales 2025 * | 15.98B 191M | Capitalization | 81.62B 977M |
---|---|---|---|---|---|
Net income 2024 | 3B 35.93M | Net income 2025 * | 3.02B 36.12M | EV / Sales 2024 | 5.17 x |
Net cash position 2024 * | 2.32B 27.83M | Net cash position 2025 * | 3.57B 42.72M | EV / Sales 2025 * | 4.88 x |
P/E ratio 2024 |
26.9
x | P/E ratio 2025 * |
27.2
x | Employees | 1,554 |
Yield 2024 * |
0.19% | Yield 2025 * |
0.15% | Free-Float | 62.32% |
Latest transcript on Neuland Laboratories Limited
1 day | +2.82% | ||
1 week | +6.53% | ||
Current month | +8.30% | ||
1 month | +7.98% | ||
3 months | +15.87% | ||
6 months | +25.26% | ||
Current year | +23.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/02/01 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/22/23 |
Chief Tech/Sci/R&D Officer | - | 22/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 31/22/31 | |
Director/Board Member | 80 | 12/19/12 | |
Sugata Sircar
BRD | Director/Board Member | 60 | 27/23/27 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 6,561 | +3.13% | 2 697 |
12/24/12 | 6,362 | -2.15% | 1,807 |
11/24/11 | 6,502 | +3.79% | 1,345 |
10/24/10 | 6,264 | -0.55% | 2,005 |
07/24/07 | 6,299 | +2.58% | 845 |
Delayed Quote Bombay S.E., June 13, 2024 at 01:53 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.72% | 978M | |
+48.79% | 781B | |
+42.03% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.60% | 248B | |
+0.12% | 221B | |
+11.55% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- NEULANDLAB Stock